Nav: Home

Ageing research to accelerate with experimental validation in AI-powered drug discovery

September 04, 2019

Wednesday, September 4th, 2019, London, UK: The Biogerontology Research Foundation salutes its Founder and Chief Scientific Advisor Alex Zhavoronkov on leading a team of researchers who have succeeded to use Artificial Intelligence to design, synthesize and validate a novel drug candidate in just 46 days, compared to the typical 2-3 years required using the standard hit to lead (H2L) approach used by the majority of pharma corporations.

By using a combination of Generative Adversarial Networks (GANs) and Reinforcement Learning (RL), the team of Insilico Medicine researchers behind this study (documented in a paper published in Nature Biotechnology this month) have succeeded in validating the real power that AI has to expedite timelines in drug discovery and development, and to transform the entire process of bringing new drugs to market from a random process rife with dead ends and wrong turns to an intelligent, focused and directed process, that takes into account the specific molecular properties of a given disease target into account from the very first step.

The Biogerontology Research Foundation has collaborated with Insilico Medicine on a number of projects and studies, and has long advocated for the extreme potentials that AI has in terms of making the process of discovering and validating new drugs a faster and more efficient process, especially as it pertains to aging and longevity research and the development of drugs capable of extending human healthspan and compressing the incidence of age-related disease into the last few years of life.

While this is the newest in a long line of steps and accomplishments aiming to turn the theoretical potentials of AI for longevity research into practice, it is also the largest step made thus far, and goes a very long way in terms of proving that potential via hard science.

"This newest achievement made by Insilico Medicine, a leading AI for drug discovery and longevity company and an official partner of Ageing Research at King's, demonstrates the truly disruptive potential that AI holds in terms of accelerating the pace of progress in drug discovery. Furthermore, this is just the latest step in a much grander agenda of applying AI for ageing and longevity R&D, and to the accelerated translation of that research into real-world therapies for human patients. It is also quite notable that the team released the code behind their algorithm in an open-source format, allowing other researchers to apply their techniques and build upon their achievements for the advancement of the entire field of AI for drug design, ageing research and longevity" said Richard Siow, Ph.D., Director of Ageing Research at King's College London and former Vice-Dean (International), Faculty of Life Sciences & Medicine, King's College London.

It is the hope of the Biogerontology Research Foundation that this study motivates additional researchers to harness the potential for AI in longevity research, and provides incentives for larger drug developers to begin on-boarding AI into their drug discovery and development programs, in order to expedite the time it takes to bring life-saving drugs into the hands of real patients.

The Biogerontology Research Foundation also salutes the team's decision to release the code behind the GAN-RL method to the public in a freely-available open-source format, so that other researchers have the power to take this approach and apply it to their own work.
-end-
Reference to the paper:

Alex Zhavoronkov, Yan A. Ivanenkov, Alex Aliper, Mark S. Veselov, Vladimir A. Aladinskiy, Anastasiya V. Aladinskaya, Victor A. Terentiev, Daniil A. Polykovskiy, Maksim D. Kuznetsov, Arip Asadulaev, Yury Volkov, Artem Zholus, Rim R. Shayakhmetov, Alexander Zhebrak, Lidiya I. Minaeva, Bogdan A. Zagribelnyy, Lennart H. Lee Tao Guo, Ala?n Aspuru-Guzik, 2019, Deep learning enables rapid identification of potent DDR1 kinase inhibitors, Nature Biotechnology

DOI: 10.1038/s41587-019-0224-x

Web link: https://www.nature.com/articles/s41587-019-0224-x

About the Biogerontology Research Foundation

The Biogerontology Research Foundation is the UK's leading non-profit focused on Longevity, supporting ageing research and multiple initiatives relating to advancing Healthy Longevity and expediting the coming paradigm shift from disease treatment to personalized precision prevention. It was the main initial donor that provided financial and organisational support to Longevity International UK for the purpose of establishing the UK All-Party Parliamentary Group for Longevity. It was also actively involved in the successful initiative of adding a new extension code for "ageing-related diseases" accepted in 2018 by the World Health Organization during the last revisions of its International Classification of Diseases framework.

Biogerontology Research Foundation

Related Ageing Articles:

How to slow down ageing?
Healthy ageing has become one of the priorities of research in Europe.
Newly confirmed biochemical mechanism in cells is key component of the anti-ageing program
Scientists from Russia, Germany and Switzerland now confirmed a mechanism in mouse, bat and naked mole rat cells -- a 'mild depolarization' of the inner mitochondrial membrane -- that is linked to ageing: Mild depolarization regulates the creation of mitochondrial reactive oxygen species (mROS) in cells and is therefore a mechanism of the anti-ageing program.
Mediterranean diet promotes gut bacteria linked to 'healthy ageing' in older people
Eating a Mediterranean diet for a year boosts the types of gut bacteria linked to 'healthy' ageing, while reducing those associated with harmful inflammation in older people, indicates a five-country study, published online in the journal Gut.
Study uses eye movement test to confirm brain ageing effects
A new study, published in PeerJ, shows how University of Liverpool researchers have used a newly developed eye movement test to improve the understanding of how parts of the brain work.
Identification of a key protein linked to ageing
Ageing is a dramatic public health issue in the face of the current demographic changes: the proportion of 60 and over in the world's population will almost double by 2050.
Bacteria in the gut may alter ageing process, finds NTU Singapore study
An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that microorganisms living in the gut may alter the ageing process, which could lead to the development of food-based treatment to slow it down.
Heavy smoking can have a damaging effect on facial ageing, study shows
Heavy smoking may have a causal effect on facial ageing, according to new research led by the University of Bristol.
Experts propose new healthcare framework to help ageing populations stay healthier longer
An international team of researchers have put forward a position statement, published in Science, which lays out a new healthcare framework to help aging populations stay healthier for longer.
The Physiological Society urges Government step change to meet its own Ageing Society target
The UK Government is at risk of missing its target to increase healthy life expectancy by five years by 2035, according to a new report, Growing Older, Better, published by The Physiological Society on Tuesday Oct.
New study challenges our understanding of premature ageing
Disturbances in the function of mitochondrial DNA can accelerate the ageing process in ways that are different than previously thought, according to a new Finnish study published in Nature Metabolism.
More Ageing News and Ageing Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.